1
Total Mentions
1
Documents
0
Connected Entities
Organization referenced in documents
EFTA00598622
Morgan Stanley Stock Rating Equal-weight Industry View In-Une J , 21 2: I - Gilead Sciences Inc. HCV Still Near and LT Focus Upside Sovaldi (4611M vs cons) drove a $0.57 EPS beat: Sovaldi (4611M), Truvada (+$18M), Viread (+$24M) and Complera
No connected entities